Back to search

Aristotle University Of Thessaloniki (AUTH)

Ο ρόλος της λιπονεκτίνης και της βισφατίνης στη ινσουλινοαντίσταση και στη μη-αλκοολική νόσο λιπώδους ήπατος

Abstract

dc:description

Introduction: Adipose tissue has emerged as endocrine tissue by producing various adipocytokines and cytokines. Although their specific role has not been defined yet, adipocytokines and cytokines seem to affect insulin sensitivity and inflammation, thereby playing a key-role in insulin resistance syndrome and related morbidities, including nonalcoholic fatty liver disease (NAFLD). Aims: The main aims of the present study were the following: 1) measurements of total and high molecular weight (HMW) adiponectin, and visfatin in insulin resistance syndrome and NAFLD Greek patients, 2) investigation of their correlation with other serological parameters, possibly involved in the pathogenesis of NAFLD, and 3) investigation of the presence of independent predictors of nonalcoholic steatohepatitis (NASH) and possibly the introduction of a potential non-invasive model predicting NASH. Methods: Thirty patients with biopsy-proven NAFLD and 24 healthy controls matched for gender, age, body mass index (BMI) and waist circumference, were consequently recruited in the present series. History, physical examination and fasting blood samples for serological analysis were obtained the same day, before liver biopsy. Based on liver histologic data, the patients were further divided into those with simple nonalcoholic fatty liver (NAFL) and those with nonalcoholic steatohepatitis (NASH). Conclusions: The results of the present series revealed that serum total and HMW adiponectin, but not visfatin, levels were decreased in patients with NAFL or NASH compared with the controls, though were similar between NAFL and NASH patients. Total, but not HMW, adiponectin could predict hepatic fibrosis independently from gender, age and BMI. There was no correlation between adiponectin and visfatin levels, a finding also reported by populations different from NAFLD. This study launches, for the first time, the introduction of the non-invasive index, named HSENSI (Homocysteine, SGOT and Erythrocyte sedimentation rate, Nonalcoholic Steatohepatitis Index), which is based on relatively simple serum measurements (homocysteine, SGOT and erythrocyte sedimentation rate) and can effectively predict NASH with sensitivity 73.3% and specificity 86.7%.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Polyzos, Stergios
  • Πολύζος, Στέργιος

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28278

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Polyzos, Stergios; Πολύζος, Στέργιος. Ο ρόλος της λιπονεκτίνης και της βισφατίνης στη ινσουλινοαντίσταση και στη μη-αλκοολική νόσο λιπώδους ήπατος. Aristotle University Of Thessaloniki (AUTH), 2012. http://hdl.handle.net/10442/hedi/28278